Prakt. lékáren. 2020; 16(3): 139-146 [Pediatr. praxi 2019; 20(6): 339-346]

Significance of vitamin C for children's body

František Kopřiva1, Pavel Frühauf2, Boris Hruškovič3, Pavel Kostiuk4, Zdeněk Procházka4, Lucie Kotlářová4, Jiří Slíva5, Vendula Látalová1, Jan Boženský6
1 Dětská klinika FN a LF UP, Olomouc
2 Klinika dětského a dorostového lékařství 1. LF UK a VFN, Praha
3 Imunologické a alergologické privátne centrum, Bratislava
4 Edukafarm, Praha
5 Ústav farmakologie 3. LF UK, Praha
6 Vítkovická nemocnice, a. s., Ostrava-Vítkovice

Vitamin C is one of the essential nutritional elements and is an irreplaceable substance for man, playing a crucial role at all stages of life. Due to its effect on the genome and because of its epigenetic role, vitamin C influences the development as well as health status at all stages of prenatal and postnatal development. It has a major impact on various functions of the immune system. It is a cofactor in a number of enzymes catalysing important reactions in the biosynthesis of indispensable substances (e.g. neurotransmitters, carnitine, collagen). It is one of the most significant antioxidants protecting tissues from oxidative stress, thereby having an anti-inflammatory effect, too. Its sufficient level is thus important in preventing numerous chronic inflammatory conditions. Vitamin C deficiency fundamentally threatens human health and is surprisingly frequent even in developed countries. The physiological need for vitamin C varies with age, ranging from 50 mg/day in newborns to 100 mg/day in adolescence and adulthood. This need increases in a number of conditions, such as physical and mental exertion, infectious and inflammatory diseases, oxidative stress-related diseases, convalescence, wound healing, and other conditions. Therefore, a sufficient supply of vitamin C in an appropriate dose and form must be maintained that would ensure its optimal bioavailability.

Keywords: vitamin C, scurvy, antioxidant, epigenetics, immunity, recurrent infection, allergy, deficiency, inflammation, evidence of deficiency, liposomal form.

Published: October 8, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kopřiva F, Frühauf P, Hruškovič B, Kostiuk P, Procházka Z, Kotlářová L, et al.. Significance of vitamin C for children's body. Praktické lékárenství. 2020;16(3):139-146.
Download citation

References

  1. Mandl J, Szarka A, Banhegyi G. Vitamin C: Update on physiology and pharmacology. Br J Pharmacol 2009; 157: 1097-1110. Go to original source...
  2. Carr AC, Maggini S. Vitamin C and Immune Function. Nutrients 2017; 9: 1211. Go to original source...
  3. Camarena V, Wang G. The Epigenetic Role of Vitamin C in Health and Disease. Cell Mol Life Sci 2016; 73: 1645-1658. Go to original source...
  4. Bozonet SM, Carr AC, Pullar JM, et al. Enhanced human neutrophil vitamin C status, chemotaxis and oxidant generation following dietary supplementation with vitamin C‑rich SunGold kiwifruit. Nutrients 2015; 7: 2574-2588. Go to original source... Go to PubMed...
  5. Jiang L, Diaz PT, Best TM, et al. Molecular characterization of redox mechanisms in allergic asthma. Ann Allergy Asthma Immunol 2014; 113: 137-142. Go to original source...
  6. Vollbracht C, Raithel M, Krick B, et al. Intravenous vitamin C in the treatment of allergies: an interim subgroup analysis of a long‑term observational study. J Intern Med Res 2018; 46: 3640-3655. Go to original source...
  7. Weber P, Bendich A, Schalch W. Vitamin C and human health - a review of recent data relevant to human requirements. Internat J Vit Nutr Res 1996; 66: 19-30.
  8. Cahill L, Corey PN, El‑Sohemy A. Vitamin C deficiency in a population of young Canadian adults. Am J Epidemiol 2009; 170: 464-471. Go to original source...
  9. Vinas BR, Barba LR, Ngo J, et al. Projected prevalence of inadequate nutrient intakes in Europe. Ann Nutr Metab 2011; 59: 84-95. Go to original source...
  10. Hampl, Taylor, Johnston. Vitamin C deficiency and depletion in United states: the third National Health and Nutrition Examination Survey, 1988 to 1994. Am J Public Health 2004; 94: 870-875. Go to original source...
  11. Khaw KT, Bingham S, Welch A, et al. Relation between plasma ascorbic acid and mortality in men and women in EPIC‑Norfolk prospective study: a prospective population study. Lancet 2001; 357: 657-663. Go to original source...
  12. Deicher R, Zitai F, Bieglmayer C, et al. Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients. J Am Soc Nephrol 2005; 16: 1811-1818. Go to original source... Go to PubMed...
  13. Hagfors L, Leanderson P, Sköldstam L, et al. Antioxidant intake, plasma antioxidants and oxidative stress in a randomized, controlled, parallel, mediterranean dietary intervention study on patients with rheumatoid arthritis. Nutr J 2003; 2: 5-15. Go to original source... Go to PubMed...
  14. Mayland CR, Bennett MI, Allan K. Vitamin C deficiency in cancer patients. Palliat Med 2005; 19: 17-20. Go to original source...
  15. Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Ann Rev Pharmacol Toxicol 2004; 44: 239-267. Go to original source...
  16. Mikirova N, Casciari J, Rogers A, et al. Effect of high‑dose intravenous vitamin C on inflammation in cancer patients. J Transl Med 2012; 10: 189. Go to original source... Go to PubMed...
  17. Teco Diagnostics. Technical file: Urine reagent strips - Ascorbic acid (CURS-1 A). Data on file.
  18. Buchanec J, Mikler J, Ďurdík P, et al. Vitamín C - čo a nem (ne)vieme. Pediatr. praxi 2005; 6: 16-19.
  19. Sherman DL, Keaney Jr. JF, et al. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension 2000; 35: 936-941. Go to original source... Go to PubMed...
  20. Ma Y, Chapman J, Levine M, Polireddy K, Drisko J, Chen Q. High‑dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci Transl Med 2014; 6: 222ra18. Go to original source...
  21. Hoffer LJ, Levine M, Assouline S, et al., Phase I clinical trial of intravenous ascorbic acid in advanced malignancy. Ann Oncol 2008; 19: 1969-1974. Go to original source...
  22. Yeom CH, Jung GC, Song KJ. Changes of terminal cancer patients' health‑related quality of life after high dose vitamin C administration. J Korean Med Sci 2007; 22: 7-11. Go to original source...
  23. Vollbracht C, Schneider B, Leendert V, et al. Intravenous vitamin C administration of vitamin C improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany. In Vivo 2011; 25: 983-990. Go to PubMed...
  24. Monti DA, Mitchell E, Bazzan AJ, et al. Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS One 2012; 7(1): e29794. Go to original source... Go to PubMed...
  25. Welsh JL, Wagner BA, van't Erve TJ, et al. Pharmacological ascorbate with gemcitabine for the control of metastatic and node‑positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Cancer Chemother Pharmacol 2013; 71(3): 765-775. Go to original source... Go to PubMed...
  26. Ma Y, Chapman J, Levine M, Polireddy K, Drisko J, Chen Q. High‑dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci Transl Med 2014; 6: 222ra18. Go to original source...
  27. Gillis et a., Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease. Clin Kidney J 2018; 11(4): 532-539. Go to PubMed...
  28. Riedl MA, Nel AE. Importance of oxidative stress in the pathogenesis and treatment of asthma. Curr Opin Allergy Clin Immunol 2008; 8: 49-56. Go to original source...
  29. Fan C, Pacier C, Martirosyan DM. Rose hip (Rosa canina L): A functional food perspective. Funct Foods Health Dis 2014; 4: 493-509. Go to original source...
  30. Mármol I, Sánchez‑de‑Diego C, Jiménez‑Moreno N, et al. Therapeutic applications of rose hips from different rosa species. Int J Mol Sci 2017; 18: 1137. Go to original source...
  31. Patel S. Rose hips as complementary and alternative medicine: overview of the present status and prospects. Mediterr J Nutr Metab 2013; 6(2): 89-97. Go to original source...
  32. Winther K, Vinther Hansen AS, Campbell‑Tofte J. Bioactive ingredients of rose hips (Rosa canina L.) with special reference to antioxidative and anti‑inflammatory properties: in vitro studies. Botanics 2016: 6: 11-23. Go to original source...
  33. Nagatomo A, Nishida N, Fukuhara I, et al. Daily intake of rosehip extract decreases abdominal visceral fat in preobese subjects: a randomized, double‑blind, placebo‑controlled clinical trial. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015; 8: 147-156. Go to original source... Go to PubMed...
  34. Fattahi A, Niyazi F, Shahbazi B, et al. Antidiabetic Mechanisms of Rosa canina Fruits: An In Vitro Evaluation. J Evid Based Complementary Altern Med 2017; 22: 127-133. Go to original source...
  35. Seifi M, Abbasalizadeh S, Mohammad‑Alizadeh‑Charandabi S. The effect of Rosa (L. Rosa canina) on the incidence of urinary tract infection in the puerperium: A randomized placebo controlled trial. Phytother Res 2018; 32: 76-83. Go to original source...
  36. Státní zdravotní ústav. Zdravotní tvrzení. Základní informace k používání zdravotních tvrzení na obalech potravin a v reklamě na potraviny. http://www.szu.cz/tema/bezpecnost‑potravin/zdravotni‑tvrzeni. (Accessed 28. 8. 2019)




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.